指南与共识血栓与止血

美国血液学会2018年静脉血栓栓塞症管理指南:儿童静脉血栓栓塞症的治疗

American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.
指南 / 共识 · Blood Adv · 2018-01-01

美国血液学会(ASH)组织多学科指南小组,基于截至2017年4月的系统证据评价,采用GRADE方法就儿童静脉血栓栓塞症管理达成30条推荐,涵盖症状性与无症状性深静脉血栓、中心静脉通路装置相关VTE、肾静脉与门静脉血栓、脑静脉窦血栓及纯合子蛋白C缺乏症。

要点

  • 指南针对儿童VTE治疗共达成30条推荐,重点为中央静脉通路装置相关VTE的管理。
  • 推荐范围涵盖有症状与无症状深静脉血栓、肾静脉及门静脉血栓、脑静脉窦血栓和纯合子蛋白C缺乏症。
  • 指南基于GRADE方法制定,证据检索截至2017年4月,并经过公开评论。

核心结论

  • 指南小组提供了多条推荐,但仍需进一步研究,重点包括无症状血栓的自然史、可对儿童进行风险分层以升级治疗的亚组界限以及新型抗凝药在儿童中的适当研究。

研究设计与样本

  • ASH成立了多学科指南小组,包括2名患者代表,并保持平衡以减少利益冲突带来的潜在偏倚。
  • 麦克马斯特大学GRADE中心支持指南制定过程,包括更新或执行系统证据评价,检索截至2017年4月。
  • 小组按对临床医生和患者的重要性排序临床问题与结局,采用GRADE方法(包括GRADE证据到决策框架)评估证据并形成推荐,推荐经过公开评论。

主要发现

  • 指南小组就儿童VTE管理达成30条推荐,覆盖有症状性和无症状性深静脉血栓,并特别关注中央静脉通路装置相关VTE的管理。
  • 推荐还涉及肾静脉血栓、门静脉血栓、脑静脉窦血栓以及纯合子蛋白C缺乏症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出,尽管小组提供了多条推荐,但仍需进一步研究。
  • 研究重点包括理解无症状血栓的自然史、确定能够对儿童进行风险分层以升级治疗的亚组界限,以及新型抗凝药在儿童中的适当研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite an increasing incidence of venous thromboembolism (VTE) in pediatric patients in tertiary care settings, relatively few pediatric physicians have experience with antithrombotic interventions. OBJECTIVE: These guidelines of the American Society of Hematology (ASH), based on the best available evidence, are intended to support patients, clinicians, and other health care professionals in their decisions about management of pediatric VTE. METHODS: ASH formed a multidisciplinary guideline panel that included 2 patient representatives and was balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline-development process, including updating or performing systematic evidence reviews (up to April of 2017). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment. RESULTS: The panel agreed on 30 recommendations, covering symptomatic and asymptomatic deep vein thrombosis, with specific focus on management of central venous access device-associated VTE. The panel also addressed renal and portal vein thrombosis, cerebral sino venous thrombosis, and homozygous protein C deficiency. CONCLUSIONS: Although the panel offered many recommendations, additional research is required. Priorities include understanding the natural history of asymptomatic thrombosis, determining subgroup boundaries that enable risk stratification of children for escalation of treatment, and appropriate study of newer anticoagulant agents in children.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018. PMID: 30482766. doi:10.1182/bloodadvances.2018024786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。